Susquehanna International Group
APTO

Susquehanna International Group’s Aptose Biosciences, Inc. APTO Stock Holding History

Susquehanna International Group’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-34
Closed -$51K – 13854
2021
Q2 		$51K Sell
34
-32
-48% -$69.7K ﹤0.01% 12298
2021
Q1 		$178K Buy
66
+6
+10% +$11.9K ﹤0.01% 11519
2020
Q4 		$119K Buy
+60
New +$141K ﹤0.01% 10407
2020
Q3 		– Sell
-41
Closed -$116K – 11341
2020
Q2 		$116K Sell
41
-281
-87% -$907K ﹤0.01% 9423
2020
Q1 		$860K Buy
322
+60
+23% +$179K ﹤0.01% 5740
2019
Q4 		$668K Buy
262
+85
+48% +$111K ﹤0.01% 6356
2019
Q3 		$165K Buy
177
+121
+216% +$138K ﹤0.01% 9256
2019
Q2 		$65K Buy
+56
New +$51.5K ﹤0.01% 9775

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Susquehanna International Group's APTO Position: Q1 2022 in Review

Susquehanna International Group sold out of Aptose Biosciences, Inc. (APTO) in Q1 2022, closing a stake of 162 shares — an estimated $99K sold.

Susquehanna International Group first reported a position in APTO in Q2 2018 and held it in 14 quarters. The position peaked at $837K in Q1 2020. 52 funds tracked by Wall St. Rank hold APTO as of Q1 2022.

  • Susquehanna International Group reported no remaining Aptose Biosciences, Inc. position as of Q1 2022 after selling out during the quarter.
  • Susquehanna International Group sold 162 Aptose Biosciences, Inc. shares in Q1 2022, an estimated $99K.
  • Susquehanna International Group first reported a position in Aptose Biosciences, Inc. in Q2 2018 and held it in 14 quarters.
  • Susquehanna International Group's Aptose Biosciences, Inc. position peaked at $837K in Q1 2020.
  • 52 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2022.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.